Sign in with Google. Opens in new tab
ENTITY
SMARTSCORE: 4/5
Dr. Reddy's Laboratories

Dr. Reddy's Laboratories (DRRD IN)

198
Analysis
Health CareIndia
Dr. Reddy's Laboratories Limited provides a complete range of pharmaceutical services. The Company manufactures bulk drugs and formulations including verapamil and cephalexin. The Company also manufactures and exports molecules such as norfloxacin, ciprofloxacin, and varieties of semi-synthetic penicillin. The Company markets its products in India and around the world.
more
29 Jul 2024 13:33

Dr. Reddy's Laboratories (DRRD IN): US and India Drive Q1FY25 Result; Announces 1:5 Stock Split

Dr. Reddy's had a good start to FY25, with a record high quarterly revenue of INR77B in Q1FY25, beating estimates, driven by robust performance...

Logo
430 Views
Share
26 Jul 2024 20:59

Pullback Underway; Getting Defensive; Long-Term RS Bottoms for Defensives Is a Reason for Caution

Pullback Underway $ACWI $SPX; Getting Defensive; Long-Term RS Bottoms for Defensive Sectors is a Reason for Caution. Buys in Health Care,...

Logo
484 Views
Share
23 Jul 2024 02:15

Sai Life Sciences Pre-IPO Tearsheet

SAI Life Sciences(SLS) is looking to raise up to US$500m in its upcoming India IPO. The deal will be run by Kotak, IIFL, Jefferies and MS.

Logo
389 Views
Share
27 Jun 2024 14:00

Dr. Reddy's Laboratories (DRRD IN): Nicotinell Acquisition to Fortify Consumer Healthcare Business

Dr. Reddy's is acquiring Haleon’s global portfolio of consumer healthcare brands in the nicotine replacement therapy outside US for £500M ($633M)....

Logo
495 Views
Share
bullishSiemens Ltd
09 Jun 2024 21:40

NIFTY200 Momentum30 Index Rebalance: 13 Changes, 42% Turnover, Momentum Recovers After Selloff

There are 13 changes for the Nifty200 Momentum 30 Index. Estimated one-way turnover is 42.3% resulting in a one-way trade of INR 32bn. The adds...

Logo
597 Views
Share
x